Volition
@VolitionRx
Followers
1K
Following
464
Media
347
Statuses
2K
We are dedicated to revolutionizing the diagnosis and monitoring of life-altering diseases by advancing the science of epigenetics.
Henderson, Nevada, USA
Joined January 2011
We can't wait to meet you at #AVMA2025 this weekend! . Stop by booth 1441 to hear the latest updates on Nu.Q® Vet, our simple blood test to aid early detection of cancer in dogs. #VetMed #CanineCancer.
0
2
3
NEWS: Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation. Read more in our press release:
0
1
3
Curious about utilising the Nu.Q® Vet Cancer Test in your practice?. Join our free webinar TOMORROW for practical tips, case studies, and more!. 📅 July 16.⌚ 8pm BST/3pm ET/12 noon PT.🔗 Register here: #VetWebinar #VeterinaryMedicine #CanineCancer.
0
1
3
In our new paper, published in @jbiolchem, we aim to inform about our Nu.Q® immunoassays, which can be applied at all stages of drug development, from cell models to patient blood samples. Download:
0
6
9
Curious about utilising the Nu.Q® Vet Cancer Test in your practice?. Join our free webinar for practical tips, case studies, and more!. 📅 July 16.⌚ 8pm BST/3pm ET/12 noon PT.🔗 Register here: #VetWebinar #VeterinaryMedicine #CanineCancer.
0
1
4
NEWS: Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes. Read the press release:
0
2
6
Join our poster presentation at #ISTH2025 today:. ⌚1:45 PM - 2:45 PM EDT.Poster number: PB1615
0
0
2
New MARS Consortium Clinical Study Suggests Nu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure. Learn more in our press release:
0
2
4
Volition announces two oral presentations at the Asian Meeting of Animal Medicine Specialties, highlighting advances in veterinary diagnostics. Find out more:
0
1
2
RT @stopsepsisnow: 32% of adults in Northern Ireland say they confidently know what sepsis is. A new YouGov survey commissioned by Sepsis….
0
1
0
This Intensive Care Week, we’re shining a light on the people, progress, and possibilities behind #criticalcare. We sat down with our Chief Medical Officer, Dr. Andrew Retter, to discuss the evolution of intensive care, from the pressures of the pandemic to the promise of AI and
0
1
3
On-Demand Webinar: Early Detection with Canine Cancer Screening 🐶. Explore the challenges and unmet needs in diagnosing canine cancer with insights from Dr. Sue Ettinger (aka @DrSueCancerVet) — a leading expert in veterinary oncology. This RACE-approved webinar covers:. ✅
0
1
1
Meet our Chief Operating Officer, Gaetan! . Gaetan has been with Volition for 10+ years, expanding operations not only in Europe, but also in the U.S. Find out more:
0
1
3
Some Nu.Q® Vet Cancer Test questions we get asked often, answered by Dr. Lisa Lippman! . Find out more on our website:
0
2
3
Nu.Q® Discover is a valuable research tool to support your drug discovery and development need, from target identification to validation, in clinical studies. Find out more:
0
3
4
Explore how epigenetics is transforming lung cancer diagnostics, offering earlier detection, greater precision, and renewed hope. Read how Volition's technology is lighting the way forward in #LungCancer detection: #LungCancerAwareness #Epigenetics.
0
2
4
NEWS: VolitionRx has published the first study to report the detection of nucleosomes in cats. Read our press release for more information: #FelineCancer #Epigenetics.
0
3
5
We have just announced our Q1 2025 financial results and business update. Join our conference call tomorrow at 8:30 a.m. ET to find out more. Read our press release:
0
2
3
We received the Young Investigator Bronze Award for our 'Advances in Liquid Biopsy for Glioblastoma Diagnosis and Monitoring through Nucleosome Epigenetic Modifications Tracking' poster at #ISMRC2025!. View the posters presented:.
0
1
5